Testicular checks, skin exams, colon and prostate risk discussions and timing.
An article joins this feed when it matches these terms. Each one is also a search of its own.
The intestines use the rhythm of a signal to decide which cells to make, improving our understanding of healthy tissue maintenance and disease disruption. The intestines have one of the highest cell turnover rates in the human body. They renew…
This is the second part of the malignant lymphoma series. In this installment, as a specialized topic, I will talk about what a pathologist does from the moment they receive a lymph node until they determine a single diagnosis. Last…
New research shows the HDAC inhibitor givinostat stalls colorectal cancer growth by upregulating miR-1938 to suppress ADAM12, with no systemic toxicity in mice. Subject of Research: Pharmacology and molecular oncology of colorectal cancer Article Title: ITF2357 exerts anti‑tumor activity in colorectal…
A matched study of more than 30,000 appendicitis patients found that those who underwent an appendectomy had a 58 percent lower relative risk of a later colorectal cancer diagnosis than those treated with antibiotics alone.
Bioengineer.org Subject of Research: Probiotic Metabolites Show Anti-Tumor Effects in Colorectal Cancer Cells Article Title: Targeting the gut–tumor axis: probiotic therapy as an adjunct strategy in colorectal cancer treatment News Source: Nathaniel Bowman. (October 17, 2026). Probiotic Metabolites Show Anti-Tumor…
Lucia Santorelli, Postdoctoral Researcher at Tigem, shared on LinkedIn: “The publication of our IANGCRC study marks an important step forward in understanding Early‑Onset Colorectal Cancer. Yet scientific progress never tells the whole story. Behind every project lie stories that…
(NASDAQ:PDSB) 2026-10-17 Seeking Alpha The following slide deck was published by PDS Biotechnology Corporation in conjunction with this event.
Colorectal cancer is one of the most common and deadliest malignancies worldwide, and its spread to the liver is the single greatest threat to patient survival. Once the disease metastasizes to distant organs, the five-year survival rate drops below twenty
Colorectal cancer remains one of the world's most formidable health challenges, ranking as the second leading cause of cancer-related mortality and the third most frequently diagnosed malignancy. With an annual incidence of 35.1 per 100,000 people and a mortality rate